Stocksigma LogoStocksigma Logo

Godavari Biorefineries Secures US Patent for Novel Cancer Treatment Compounds

Godavari Biorefineries Limited has been granted a US patent for "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER," as disclosed on 14th

Godavari Biorefineries Secures US Patent for Novel Cancer Treatment Compounds

Godavari Biorefineries Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 11:32 pm

Godavari Biorefineries Secures US Patent for Novel Cancer Treatment Compounds Godavari Biorefineries Limited has been granted a US patent for "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER," as disclosed on 14th Oct'26. The patent protects a novel class of compounds engineered to inhibit cancer and cancer stem cells, demonstrating strong therapeutic potential across multiple indications, including breast and prostate cancers. The approval strengthens the company's proprietary oncology pipeline and global intellectual property portfolio.

Original exchange filing (PDF)

More announcements from Godavari Biorefineries Ltd

All Godavari Biorefineries Ltd announcements